Aldesleukin Intravenous and Nabilone
Determining the interaction of Aldesleukin Intravenous and Nabilone and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Sedatives, tranquilizers, muscle relaxants, antidepressants, and other central nervous system (CNS) depressants may have additive CNS-depressant effects with aldesleukin. Aldesleukin has been associated with CNS effects including depression, confusion, and drowsiness, which may progress to coma. MANAGEMENT: Caution is advised if aldesleukin is used with sedatives, hypnotics, tranquilizers, or other CNS-active medications. Patients should be monitored for CNS depression and other CNS adverse effects. Treatment with aldesleukin should be discontinued if severe lethargy or somnolence develop. References Agencia Española de Medicamentos y Productos Sanitarios Healthcare "Centro de información online de medicamentos de la AEMPS - CIMA. Available from: URL: https://cima.aemps.es/cima/publico/home.html." ([2018]): "Product Information. Proleukin (aldesleukin)." Chiron Therapeutics, Emeryville, CA. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Professional:MONITOR: Sedatives, tranquilizers, muscle relaxants, antidepressants, and other central nervous system (CNS) depressants may have additive CNS-depressant effects with aldesleukin. Aldesleukin has been associated with CNS effects including depression, confusion, and drowsiness, which may progress to coma.
MANAGEMENT: Caution is advised if aldesleukin is used with sedatives, hypnotics, tranquilizers, or other CNS-active medications. Patients should be monitored for CNS depression and other CNS adverse effects. Treatment with aldesleukin should be discontinued if severe lethargy or somnolence develop.
- Agencia Española de Medicamentos y Productos Sanitarios Healthcare "Centro de información online de medicamentos de la AEMPS - CIMA. Available from: URL: https://cima.aemps.es/cima/publico/home.html." ([2018]):
- "Product Information. Proleukin (aldesleukin)." Chiron Therapeutics, Emeryville, CA.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: aldesleukin
Brand name: Proleukin
Synonyms: Aldesleukin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aldesleukin Intravenous-Nabumetone
- Aldesleukin Intravenous-Nacellate Injection
- Aldesleukin Intravenous-Nadolol
- Aldesleukin Intravenous-Nadolol and Bendroflumethiazide
- Aldesleukin Intravenous-Nadopen V 200
- Aldesleukin Intravenous-Nadopen V 400
- Nabilone-Aldex G
- Nabilone-Aldex GS DM
- Nabilone-Aldomet
- Nabilone-Aldoril
- Nabilone-Aldurazyme
- Nabilone-Alecensa